Watson; Robert J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Watson; Robert J..The latest application filed is for "2,3-dihydrobenzofurans as bromodomain inhibitors".

Company Profile

16.21.22

Watson; Robert J. - Stevenage GB
Watson; Robert J. - Dallas TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
2,3-dihydrobenzohurans as bromodomain inhibitors Grant 11,319,307 - Atkinson , et al. May 3, 2	2022-05-03
Benzofuran derivatives and their use as bromodomain inhibitors Grant 11,273,146 - Atkinson , et al. March 15, 2	2022-03-15
Pyrazole derivatives as bromodomain inhibitors Grant 10,966,961 - Atkinson , et al. April 6, 2	2021-04-06
Pyridyl derivatives as bromodomain inhibitors Grant 10,934,272 - Atkinson , et al. March 2, 2	2021-03-02
Pyridinone dicarboxamide for use as bromodomain inhibitors Grant 10,927,080 - Atkinson , et al. February 23, 2	2021-02-23
Pyridyl derivatives as bromodomain inhibitors Grant 10,849,897 - Atkinson , et al. December 1, 2	2020-12-01
Pyridine dicarboxamide derivatives as bromodomain inhibitors Grant 10,844,015 - Atkinson , et al. November 24, 2	2020-11-24
Benzofuran Derivatives And Their Use As Bromodomain Inhibitors App 20200289464 - ATKINSON; Stephen John ; et al.	2020-09-17
2,3-dihydrobenzofurans As Bromodomain Inhibitors App 20200291009 - ATKINSON; Stephen John ; et al.	2020-09-17
Benzo[b]furans as bromodomain inhibitors Grant 10,583,112 - Atkinson , et al.	2020-03-10
Pyridyl Derivatives As Bromodomain Inhibitors App 20200009140 - ATKINSON; Stephen John ; et al.	2020-01-09
Pyrazole Derivatives As Bromodomain Inhibitors App 20190381010 - ATKINSON; Stephen John ; et al.	2019-12-19
Pyridinone Dicarboxamide For Use As Bromodomain Inhibitors App 20190359572 - ATKINSON; Stephen John ; et al.	2019-11-28
2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors Grant 10,471,050 - Atkinson , et al. Nov	2019-11-12
Pyridinone dicarboxamide for use as bromodomain inhibitors Grant 10,428,026 - Atkinson , et al. October 1, 2	2019-10-01
Pyridinone dicarboxamide for use as bromodomain inhibitors Grant 10,370,356 - Atkinson , et al.	2019-08-06
Pyridine Dicarboxamide Derivatives As Bromodomain Inhibitors App 20190202786 - ATKINSON; Stephen John ; et al.	2019-07-04
Benzo[b]furans As Bromodomain Inhibitors App 20190151279 - ATKINSON; Stephen John ; et al.	2019-05-23
Pyridyl Derivatives As Bromodomain Inhibitors App 20190119248 - ATKINSON; Stephen John ; et al.	2019-04-25
2-oxo-1,2-dihydropyridine-3,5-dicarboxamide Compounds As Bromodomain Inhibitors App 20180280368 - ATKINSON; Stephen John ; et al.	2018-10-04
Pyridinone Dicarboxamide For Use As Bromodomain Inhibitors App 20180282301 - ATKINSON; Stephen John ; et al.	2018-10-04
Pyridinone Dicarboxamide For Use As Bromodomain Inhibitors App 20180258044 - ATKINSON; Stephen John ; et al.	2018-09-13
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor Grant 9,861,627 - Demont , et al. January 9, 2	2018-01-09
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole And Its Use As Bromodomain Inhibitor App 20170157113 - Demont; Emmanuel Hubert ; et al.	2017-06-08
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imi- dazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor Grant 9,610,284 - Demont , et al. April 4, 2	2017-04-04
Sound treatment assembly for a fluid transmission line Grant 9,587,765 - Lin , et al. March 7, 2	2017-03-07
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole And Its Use As Bromodomain Inhibitor App 20160317529 - Demont; Emmanuel Hubert ; et al.	2016-11-03
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor Grant 9,416,130 - Demont , et al. August 16, 2	2016-08-16
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole And Its Use As Bromodomain Inhibitor App 20150315184 - Demont; Emmanuel Hubert ; et al.	2015-11-05
Sound Treatment Assembly For A Fluid Transmission Line App 20150300525 - Lin; Chun ; et al.	2015-10-22
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor Grant 9,067,936 - Demont , et al. June 30, 2	2015-06-30
Tetrahydroquinoline derivatives useful as bromodomain inhibitors Grant 9,029,395 - Amans , et al. May 12, 2	2015-05-12
7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1H-imidazo[4,5-C]quinoline derivatives Grant 8,846,709 - Demont , et al. September 30, 2	2014-09-30
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole And Its Use As Bromodomain Inhibitor App 20140171462 - Demont; Emmanuel Hubert ; et al.	2014-06-19
7-(3,5-Dimethyl-4-Isoxazolyl)-8-(Methyloxy)-1H-Imidazo[4,5-C]Quinoline Derivatives App 20140045834 - Demont; Emmanuel Hubert ; et al.	2014-02-13
Tetrahydroquinoline Derivatives Useful As Bromodomain Inhibitors App 20140039006 - Amans; Dominique ; et al.	2014-02-06
Pyrido[3,4-b]pyrazine Derivatives As Syk Inhibitors App 20140005188 - Atkinson; Francis Louis ; et al.	2014-01-02

Company Registrations

NCAGE Code	0U5U4	WATSON ROBERT J
CAGE Code	0U5U4	WATSON ROBERT J
SEC	0001257368	WATSON ROBERT J
SEC	0001202437	WATSON ROBERT J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.